Stigmata Maidis Gran (1ch-30ch) 1 Ch Tablet is a Health Canada–registered human drug (DIN 01953478) held by Homeocan Inc., containing Zea Mays. Health Canada lists its status as Cancelled Post Market (status date 20 Oct 1997). Nexara Health has matched 11 registrations of Zea Mays across 2 other regulated markets.
Health Canada registration
| DIN | 01953478 |
|---|---|
| Brand name | Stigmata Maidis Gran (1ch-30ch) |
| Active ingredient | Zea Mays |
| Strength | 1 Ch |
| Dosage form | Tablet |
| Route | Oral |
| Company | Homeocan Inc. |
| Status | Cancelled Post Market — 20 Oct 1997 |
| Class | Human |
| ATC | |
| AHFS | 92:02.00* ; See footnote |
| Regulator record | Health Canada DPD entry · Product monograph |
Zea Mays registered in other markets
11 registrations of the same molecule in 2 national registries outside Canada (first 9 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| Malaysia | Toku Tsuru STEADI CAPSULE | Mb Nutraceuticals Sdn Bhd | Natural Product | PRODUCT APPROVED | NPRA | |
| United States | Corn Food | Greer Laboratories, Inc. | Solution | listed | FDA NDC | |
| United States | Corn Pollen Pollen | Allermed Laboratories, Inc. | Injection | listed | FDA NDC | |
| United States | Cultivated Corn | Greer Laboratories, Inc. | Solution | listed | FDA NDC | |
| United States | Cultivated Corn | Greer Laboratories, Inc. | Solution | listed | FDA NDC | |
| United States | Cultivated Corn | Greer Laboratories, Inc. | Solution | listed | FDA NDC | |
| United States | Cultivated Corn | Greer Laboratories, Inc. | Solution | listed | FDA NDC | |
| United States | Cultivated Corn | Greer Laboratories, Inc. | Solution | listed | FDA NDC | |
| United States | Cultivated Corn | Greer Laboratories, Inc. | Solution | listed | FDA NDC |
See every manufacturer of Zea Mays worldwide →
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Stigmata Maidis Gran (1ch-30ch) (DIN 01953478) marketed in Canada?
No. Health Canada lists DIN 01953478 as Cancelled Post Market as of 20 Oct 1997.
Who holds the Canadian licence for this product?
Homeocan Inc. is the company of record in the Health Canada Drug Product Database.
Is Zea Mays registered outside Canada?
Yes — Nexara Health has matched 11 registrations in 2 other markets (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 01953478, status date 1997-10-20; national medicine registries: FDA NDC, NPRA. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 01953478, status date 1997-10-20; national medicine registries: FDA NDC, NPRA.
Health Canada Drug Product Database (DPD), DIN 01953478, status date 1997-10-20; national medicine registries: FDA NDC, NPRA. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.